GETI.B

182.85

+0.44%↑

EKTA.B

56.8

+0.44%↑

ATT

101

0%↓

AMBEA

129.7

-1.22%↓

ARJOB

24.92

-1.11%↓

GETI.B

182.85

+0.44%↑

EKTA.B

56.8

+0.44%↑

ATT

101

0%↓

AMBEA

129.7

-1.22%↓

ARJOB

24.92

-1.11%↓

GETI.B

182.85

+0.44%↑

EKTA.B

56.8

+0.44%↑

ATT

101

0%↓

AMBEA

129.7

-1.22%↓

ARJOB

24.92

-1.11%↓

GETI.B

182.85

+0.44%↑

EKTA.B

56.8

+0.44%↑

ATT

101

0%↓

AMBEA

129.7

-1.22%↓

ARJOB

24.92

-1.11%↓

GETI.B

182.85

+0.44%↑

EKTA.B

56.8

+0.44%↑

ATT

101

0%↓

AMBEA

129.7

-1.22%↓

ARJOB

24.92

-1.11%↓

Home・Akciju saraksts・Vivesto AB

Vivesto AB

Atvērts

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

Max

Galvenie mērījumi
By Trading Economics
Ienākumi	-1.9M -9.1M
EPS	-0.015
Darbinieki	4
EBITDA	-1.8M -8.9M

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 7. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-1.1M 50M
Iepriekšējā atvēršanas cena	0
Iepriekšējā slēgšanas cena	0

Vivesto AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 19. marts 18:34 UTC

Peļņas

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

2026. g. 19. marts 17:43 UTC

Galvenie tirgus virzītāji

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

2026. g. 19. marts 23:47 UTC

Peļņas

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

2026. g. 19. marts 23:47 UTC

Peļņas

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

2026. g. 19. marts 23:47 UTC

Peļņas

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

2026. g. 19. marts 23:47 UTC

Peļņas

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

2026. g. 19. marts 23:39 UTC

Peļņas

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

2026. g. 19. marts 23:39 UTC

Peļņas

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

2026. g. 19. marts 23:39 UTC

Peļņas

Li Ning: Outdoor Category Continued Growing >2331.HK

2026. g. 19. marts 23:38 UTC

Peļņas

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

2026. g. 19. marts 23:33 UTC

Tirgus saruna

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

2026. g. 19. marts 22:42 UTC

Iegādes, apvienošanās, pārņemšana

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

2026. g. 19. marts 22:42 UTC

Iegādes, apvienošanās, pārņemšana

McCormick Has a Market Value of Around $14.8B -- WSJ

2026. g. 19. marts 22:42 UTC

Iegādes, apvienošanās, pārņemšana

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

2026. g. 19. marts 22:42 UTC

Iegādes, apvienošanās, pārņemšana

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

2026. g. 19. marts 22:23 UTC

Tirgus saruna

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

2026. g. 19. marts 22:09 UTC

Tirgus saruna

Galvenie ziņu notikumi

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

2026. g. 19. marts 22:06 UTC

Tirgus saruna

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

2026. g. 19. marts 22:04 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

2026. g. 19. marts 22:03 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Energy Roundup: Market Talk

2026. g. 19. marts 22:03 UTC

Tirgus saruna

Galvenie ziņu notikumi

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

2026. g. 19. marts 21:51 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

2026. g. 19. marts 20:57 UTC

Galvenie ziņu notikumi

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

2026. g. 19. marts 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 19. marts 20:19 UTC

Galvenie ziņu notikumi

Brent Crude Retreats After Touching $119 -- WSJ

2026. g. 19. marts 19:49 UTC

Tirgus saruna

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

2026. g. 19. marts 19:26 UTC

Galvenie ziņu notikumi

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

2026. g. 19. marts 19:10 UTC

Tirgus saruna

Galvenie ziņu notikumi

Natural Gas Rises in Volatile Trading -- Market Talk

2026. g. 19. marts 19:06 UTC

Galvenie ziņu notikumi

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

2026. g. 19. marts 18:08 UTC

Tirgus saruna

Galvenie ziņu notikumi

Silver Extends Slide to Seven Straight Sessions -- Market Talk

Salīdzinājums

Cenas izmaiņa

Vivesto AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.